Introduction
Cells constantly face a changing environment, which is often antagonistic and not conducive for survival. Thus, in order to protect an organism against undesirable damages, cells have acquired both repair and apoptotic mechanisms. Central in mediating these organismal protective mechanisms is the tumour suppressor p53, also known as the 'Guardian of the Genome', which is activated by almost all known cellular perturbations (Brown et al., 2009; Levine and Oren, 2009 ). Upon activation, p53 has been shown to induce apoptosis to remove severely damaged cells (Zuckerman et al., 2009) . However, if the damage is limited, the cell-cycle is halted and the DNA-repair pathways are activated to correct the defects (Helton and Chen, 2007) . Years of research have indicated that either of these mechanisms can predominate, based on cooperation with various cellular cofactors, depending on the cellular context and extent of damage (Laptenko and Prives, 2006; Brooks and Gu, 2010) .
Counterintuitive to the concept of repairing or removing damaged cells is the idea of enhancing cellular protection in the face of an initial onslaught of environmental insult. It is not inconceivable that evolution would have opted for survival mechanisms that only when overrun, will give way to mechanisms that deal with the resultant damage. In this context, it has been unclear if a tumour suppressor such as p53 would have any role in protecting cells against cellular insults by directly inducing survival pathways. However, by virtue of its ability to induce cell-cycle arrest, it has been suggested that p53 activation can lead to survival (Janicke et al., 2008) . Hence, absence of p53 may lead to defective cell-cycle arrest and hence, allow the cells to undergo apoptosis. Several reports have supported this paradigm (Janicke et al., 2008; Gudkov and Komarova, 2010) . For example, absence of p53 has been shown to promote taxol-mediated death owing to failure of cell arrest in the G 1 phase of the cell cycle, and hence, allowing cells to accumulate in the G 2 /M phase where they undergo mitotic cell death (Vikhanskaya et al., 1998) . In addition, cells with wild-type p53 have been shown to be more resistant to cytotoxic drug treatment in some cases (Hermisson et al., 2006; Batista et al., 2007; Roos et al., 2007) . Other reports have also shown that absence of p53 leads to sensitization to UV irradiation and alkalyting agents in mouse embryonic fibroblasts (MEFs), and to thymoquinone-induced apoptosis in human cells (Lackinger and Kaina, 2000; Roepke et al., 2007) . Moreover, low levels of p53 were shown to confer antiapoptotic effects in MEFs (Lassus et al., 1996) . The data together point to a pro-survival role for p53.
Recent reports have also indicated that p53 is indirectly able to support survival. For instance, leukaemia-inhibitory factor-a cytokine critical for embryo implantation-was identified as a p53-regulated gene (Hu et al., 2007) . Moreover, p53 has been shown to induce as many as 40 genes that can somewhat, though not directly, have antiapoptotic effects (Janicke et al., 2008) . These include DNp73, the inhibitor of p53; Slug, the transcriptional repressor of Puma; and DcR1 and DcR2, which are TRAIL decoy receptors, to name a few (Janicke et al., 2008) . In many cases, these targets have been suggested to act in a negative feedback loop to attenuate p53 function to end the signal cascade for cells to recover from the initial damage (Janicke et al., 2008) . Nonetheless, direct p53-transactivated targets that promote p53-dependent cellular survival have not been described to our knowledge.
Haeme-oxygenase (HO) is an enzyme that catalyses the degradation of haeme into bilirubin and CO, and exists as two major catalytic forms: the inducible haeme-oxygenase-1 (HO-1) that is induced by hypoxia, oxidative stress, heavy metals such as cadmium, etc., and the constitutively expressed HO-2 (Fang et al., 2004 , Gozzelino et al., 2010 . HO-1 with its antioxidant, antiapoptotic and proangiogenic properties has been shown to be overexpressed in cancers (Ferris et al., 1999; Petrache et al., 2000; Jozkowicz et al., 2007; Gozzelino et al., 2010) . It regulates cellular homeostasis and protects against cellular and tissue injury, and consistently, HO-1-deficient mice were found to be significantly more susceptible to tissue injury than their wild-type counterparts (Chen-Roetling et al., 2005) . HO-1 has been suggested to inhibit apoptosis by decreasing intracellular pro-oxidant levels as well as by its ability to induce CO, which has been shown to inhibit the expression of p53 and the release of mitochondrial cytochrome-c (Fang et al., 2004; Gozzelino et al., 2010) .
In our attempts to uncover novel pro-survival roles of p53, we have been setting up cellular systems to reproducibly reflect the importance of p53 in cellular survival. In this report, we show that both immortalized MEFs and human colorectal RKO tumour cells lacking p53 due to genetic deletion are more susceptible to hydrogen peroxide (H 2 O 2 )-mediated death, whereas they are resistant to other conventional DNA-damaging insults such as cisplatin (CDDP) and etoposide, compared with their wild-type counterparts. We provide evidence that induction of HO-1 expression is reduced in the absence of p53, which was found to directly regulate the expression of HO-1 only in the context of H 2 O 2 treatment but not upon CDDP treatment. p53 directly binds to the HO-1 promoter and silencing of HO-1 expression leads to enhancement of cell death only in wild-type but not in p53-null cells. Altogether, the data show that p53 directly regulates survival upon specific cellular insults to promote cellular viability through activation of HO-1.
Results
Cells lacking p53 are susceptible to H 2 O 2 -mediated cell death in contrast to cisplatin-or etoposide-mediated death Immortalized p53 þ / þ and p53 À/À MEFs were first used to evaluate susceptibility to various stress signals, including H 2 O 2 and CDDP, the latter being an example of a DNA-damaging agent that induces cell death in a p53-dependent manner (Persons et al., 2000) . H 2 O 2 treatment resulted in higher levels of apoptosis in p53 À/À MEFs compared with that in p53
: 58 versus 9 for 1.6 mM, Po0.001, and 18 versus 5 for 2.2 mM, Po0.001) (Figure 1a ). By contrast and as expected, p53
À/À cells were more resistant to CDDP than p53
: 43 versus 87 for 50 mM, Po0.001, and 12 versus 66 for 80 mM CDDP, Po0.001) (Figure 1b) .
To further confirm this observation, we used isogenic human RKO colorectal cells proficient or deficient for p53 expression (Sur et al., 2009) . H 2 O 2 treatment resulted in elevated levels of apoptosis in RKOp53
: 81 versus 37 for 2 mM, Po001, and 53 versus 1 for 5 mM, Po0.001) (Figure 1c ). However, CDDP treatment resulted in reduced apoptosis in RKOp53 À/À cells (% viable cells: RKOp53
: 23 versus 54 for 50 mM CDDP, Po0.05) (Figure 1d ).
To establish the selective effect of p53 deficiency on oxidative stress-induced death, we evaluated the effects of other agents such as the chemotherapeutic drug etoposide and the nitrosative agent Sin-1. Treatment with etoposide led to cell death, which was greater in p53-proficient cells than deficient cells, similar to CDDP treatment (% viable cells:
: 62 versus 78) (Supplementary Figure 1A) . By contrast, treatment with Sin-1, which results in nitration (Zhang et al., 2009) Figure 1B) .
These data together show that lack of p53 leads to enhanced sensitivity selectively to oxidative (H 2 O 2 ) and nitrosative (Sin-1) treatment in both human and mouse cellular systems. Haeme-oxygenase-1 regulates p53-dependent survival SY Nam and K Sabapathy agents (Supplementary Figure 2A) . Consistently, serine-18 phosphorylation was induced in both cases (Supplementary Figure 2A ), although both agents did not lead to significant upregulation of acetylation at K379 (data not shown). Similar results were obtained with human RKO cells (Supplementary Figure 2B) . Analysis of target genes indicated that H 2 O 2 -or CDDP induced genes such as mdm2 and bax to varying extents in human and mouse cells, in a p53-dependent manner ( Supplementary Figures 2C and D) . Nonetheless, we were not able to identify any known p53-dependent apoptotic genes that were differentially expressed in a p53-dependent manner in H 2 O 2 -treated cells compared with CDDP-treated cells (data not shown), suggesting that the conventional p53 targets may not be causal to the differential death observed upon H 2 O 2 treatment.
HO-1 is induced in a p53-dependent manner only upon H 2 O 2 but not CDDP treatment We therefore hypothesized that p53 will be able to regulate the expression of survival genes, absence of which would lead to sensitization of p53-deficient cells. Hence, we screened for a large number of genes by reverse transcription-PCR (RT-PCR) (data not shown), including HO-1, which has been shown to be induced by oxidative stress (Choi and Alam, 1996; Motterlini et al., 2002; Fang et al., 2004) . HO-1 was found to be induced in a p53-dependent manner only upon H 2 O 2 treatment but not upon CDDP treatment in MEFs, by real-time quantitative PCR analysis ( Figure 2a ). Semi-quantitative RT-PCR confirmed these results (Supplementary Figure 3A) . Similar results were obtained in human RKO cells, where HO-1 induction was compromised in the absence of p53 (Figure 2b and Supplementary Figure 3B ). This was further confirmed at the protein level, which clearly showed that HO-1 expression was specifically induced in a p53-dependent manner only upon H 2 O 2 treatment (Figure 2c ). Importantly, HO-2 was not induced by H 2 O 2 (Supplementary Figure 3C) , highlighting that HO-1 induction is specific.
To further verify if activation of HO-1 by p53 is dependent on the stimulating signal, HO-1 expression was determined upon treatment with Sin-1 and etoposide by semi-quantitative RT-PCR. Consistent with the cell survival data (Supplementary Figures 1A and B) , only Sin-1 treatment but not etoposide treatment led to the induction of HO-1 (Supplementary Figure 3D) , confirming the signal specificity of p53-dependent HO-1 induction.
We therefore next evaluated if HO-1 activation by heavy metals like CdCl 2 or agents like hemin would occur in a p53-dependent manner. Both stimuli induced HO-1 expression similarly in wild-type and in p53-deficient cells (Figure 2d ), further indicating that the p53-dependent HO-1 induction is selective to certain stimuli.
HO-1 expression is induced by p53
We thus tested if HO-1 expression is induced by direct expression of p53. Using p53-inducible SAOS-2 cells, we noticed that HO-1 was induced upon p53 induction, similar to the expression of p21 (Figure 3a) . A comparison of the p53 homologue, p73, indicated that the latter was unable to induce HO-1 expression, signifying specificity (Figure 3b) . Moreover, transient expression of either of the wild-type polymorphic p53 (p53Pro or p53Arg) forms resulted in the induction of HO-1 expression (Figure 3c ). By contrast, the DNAbinding domain-mutant p53 (175p53) was defective in the activation of HO-1 expression, similar to mdm2 (Figure 3c ), indicating that DNA-binding activity of p53 is required for HO-1 activation.
p53 binds to HO-1 promoter upon H 2 O 2 but not CDDP treatment To determine whether p53 directly binds to the HO-1 promoter and activates its expression, we performed in vivo chromatin immunoprecipitation assays. The human HO-1 promoter contains at least two p53-response elements in the 5 0 promoter region at positions 34 099 384 and 34 102 178, referred to here as RE1 and RE2, respectively (Figure 3d ). Treatment of cells with H 2 O 2 resulted in the binding of p53 to the HO-1 RE1 site, similar in kinetics to the mdm2 promoter (Figure 3e ). However, this was not the case after CDDP treatment, although p53 bound to the mdm2 promoter in this case (Figure 3e ). These data confirm the selectivity of p53 for the HO-1 promoter upon H 2 O 2 treatment. We were unable to note the binding of p53 to the RE2 site in both cases (data not shown).
Silencing HO-1 expression promotes cell death upon H 2 O 2 treatment selectively in p53-proficient cells To confirm that p53-dependent HO-1 induction after H 2 O 2 treatment is indeed responsible for cellular survival, we silenced the expression of HO-1 in both wild-type and p53-deficient RKO cells prior to H 2 O 2 treatment. As expected, HO-1 was induced upon H 2 O 2 treatment, but the induction was dramatically reduced by HO-1-sepcific short interfering RNA (siRNA) (Figure 4a ). Analysis of cell death indicated that silencing HO-1 expression resulted in elevated cell death upon H 2 O 2 treatment (% relative cell death in control versus HO-1 siRNA: 11.1 versus 23.3 at 28 h) (Figure 4b, lower panel for quantification) . Importantly, silencing HO-1 expression in p53 À/À cells did not increase the cell death rates (% relative cell death in control versus HO-1 siRNA: 60.0 versus 40.0 at 28 h) (Figure 4b ). These data together suggest that p53-dependent HO-1 induction indeed promotes cellular survival.
H 2 O 2 -induced cell death is abrogated by treatment with antioxidants and a by-product of HO-1 metabolism, bilirubin As HO-1 is an antioxidant protein, reduction of which in the absence of p53 sensitizes cells to oxidative stressinduced death, we analysed if the levels of reduced glutathione (rGSH)-reflective of an antioxidant status-is affected in p53-null cells. Treatment with H 2 O 2 lead to a decrease of rGSH levels in RKOp53 þ / þ cells, but this was much more dramatic in RKOp53 À/À cells (% decrease in rGSH after H 2 O 2 treatment in RKOp53
: 9.8 versus 38.7) (Figure 5a ), indicating that p53 deficiency indeed leads to reduced intracellular antioxidant levels.
We therefore attempted to rescue the H 2 O 2 -induced massive cell death in RKOp53 À/À cells by pre-treating them with various antioxidants such as rGSH and N-acetylcysteine (NAC). Pre-treatment with either of these agents for 2 h prior to H 2 O 2 addition led to a major reduction in cell death, more evident in RKOp53 versus 67 for H 2 O 2 þ 5 mM bilirubin) (Figure 5c ), confirming that reconstitution of defective HO-1 function in p53-deficient cells through its by-products indeed leads to amelioration of cell death.
Discussion
The data presented here show that p53 is capable of inducing the expression of an antiapoptotic target gene HO-1-by directly binding to a responsive element on its promoter-and promoting cellular survival upon exposure to H 2 O 2 stress. These results therefore highlight that p53 can indeed provide cellular survival signals under appropriate conditions. Albeit surprising and unexpected, these findings do have some corroborative support from previous work. It was noted long back that low levels of p53 can protect cells from serum withdrawal-mediated death (Lassus et al., 1996) . Similarly, p53 was shown to function as a survival factor in the gastrointestinal tract under conditions of severe irradiation, which was attributed to increased sensitivity of vascular endothelial cells (Komarova et al., 2004; Burdelya et al., 2006) . Furthermore, other reports have identified conditions in which absence of p53 led to elevated apoptosis, but a direct causal role for p53 in providing survival signals has not been described (Lassus et al., 1996; Lackinger and Kaina, 2000; Hermisson et al., 2006; Batista et al., 2007; Roepke et al., 2007; Roos et al., 2007) . Notwithstanding these occasional reports, the major observations that p53 activation often leads to apoptosis or DNA repair have been overwhelming, and hence, have overshadowed the exploration of the survival-promoting properties of p53.
Several target genes of p53 involved in inhibiting the function of p53, such as MDM2, DNp73 and DDR1, have also been shown to inhibit the apoptotic function of p53, and have been suggested to work in a feedback loop to attenuate the initial p53 signal (Janicke et al., 2008) . However, not many p53 targets that are directly involved in inhibiting apoptosis and promoting cellular Haeme-oxygenase-1 regulates p53-dependent survival SY Nam and K Sabapathy survival have been identified. In this context, HO-1 stands out, with its antioxidant properties (Ferris et al., 1999; Petrache et al., 2000; Fang et al., 2004; Gozzelino et al., 2010) . It is noteworthy that HO-1 was noted to be induced by overepxressed p53 a decade ago by Vogelstein and co-workers, although they concluded that upon stress treatment with doxorubicin and 5-fluorouracial, HO-1 was not induced in a p53-dependent manner (Yu et al., 1999) . Recently, when our work was underway, a report showed that HO-1 can be induced in a p53-dependent manner in mouse lymphoid tissues (Meiller et al., 2007) , although the physiological consequences were not reported. Thus, our data along with the others, confirm that HO-1 is indeed a p53-dependent target gene.
An interesting point that surfaces from the presented findings is that HO-1 is not induced by all signals that activate p53. Our data show that only oxidative stress, nitrosative stress, hypoxia (mimicked by treatment with cobalt chloride) and endoplasmic stress lead to the induction of HO-1 in a p53-dependent manner (Figure 2 ; Supplementary Figure 1 , and data not shown). By contrast, CDDP and etoposide-common chemotherapeutic DNA-damaging agents-are incapable of inducing HO-1 in both the human and the mouse cell types used in this study (this report). Moreover, HO-1 was not induced by UVC irradiation (data not shown), although g-irradiation was shown to induce HO-1 expression in a p53-dependent manner (Meiller et al., 2007) . Furthermore, agents such as hemin and CdCl 2 that induce HO-1 expression do so in a p53-independent manner. Importantly, it is to be also noted that HO-1 is not inducible in a p53-dependent manner in all cell types. For example, we were unable to observe p53-dependent survival upon H 2 O 2 treatment in another human colorectal cell line, HCT116 (data not shown), and in mouse embryonic stem cells (Lee et al., 2005) . All these data therefore point to the existence of a yet to be understood signal and cellular context specificity that determines HO-1 induction and cell survival in a p53-dependent manner.
HO-1 is an antiapoptotic gene product that is overexpressed in cancers (Jozkowicz et al., 2007) , and expectedly, lack of HO-1 has been shown to lead to sensitization of cells to death (Fang et al., 2004; ChenRoetling et al., 2005; Jozkowicz et al., 2007) . Consistently, cells lacking p53 and hence expressing reduced HO-1 are also more susceptible to death, and silencing HO-1 expression promotes cells death upon H 2 O 2 treatment only in p53-proficient cells (this report), indicating that HO-1 is indeed a target of p53 that is responsible for p53-dependent cellular survival, although probably not the only. Nevertheless, the question that arises is: what are the cell-fate determinants of p53-mediated HO-1 induction? Given that HO-1 induction is affected by both signal and cellular context, it is possible that p53 promotes HO-1 expression in hypersensitive cells such as gut and lymphoid tissues that need protection against the initial onslaught of stress. Furthermore, given that general modifications such as serine-15 phosphorylation are similarly effected by H 2 O 2 or CDDP, other modifications on p53, such as oxidation, may affect promoter selectivity, as previously suggested (Buzek et al., 2002) , together with other cofactors. These hypotheses require further investigation.
Based on the fact that HO-1 is an antioxidant gene product, we analysed and found that the intracellular levels of reduced glutathione-reflective of the oxidative state of the cells-was expectedly much reduced in H 2 O 2 -treated p53-deficient cells. Consistently, addition of antioxidants such as reduced glutathione and/or the precursor NAC led to a dramatic reduction in H 2 O 2 -mediated cell death specifically in p53 À/À cells. Importantly, addition of bilirubin, a by-product of HO-1 metabolism, led to the rescue of cell death more so in p53 À/À cells, highlighting that p53 indeed regulated the oxidation state of cells through regulation of HO-1 expression, and thus, controlled cellular survival. In this context, it is noteworthy that glutathione has been shown to modulate HO-1 expression (Foresti et al., 1997; Motterlini et al., 2000) . Hence, a tight relationship appears to exist that keeps the oxidative state in balance through p53.
Taken together, the results shown here underscore the notion that p53 not only performs functions to remove or fix damaged cells, but also contributes to prevention of cellular death to allow cells to withstand negative environmental stimuli, which have to be overcome prior to fixation of the defects or the abort decision is made.
Materials and methods

Cell culture and chemicals p53
À/À and p53 þ / þ MEFs were obtained from a p53 þ /À mice inter-cross and were spontaneously immortalized as described by Sabapathy et al. (2004) . Human RKOp53 À/À and RKOp53 þ / þ cells were a gift from Dr Vogelstein (Sur et al., 2009) . Doxycycline-inducible SAOS-2 cells (p53 or p73) and human p53-null H1299 cells have been described by Vikhanskaya et al. (2007) . The H1299 cells were transfected in six-well plates using Lipofectamine (Invitrogen, Carlsbad, CA, USA) using 0.5 mg of plasmid DNA and harvested 24 h later.
For gene silencing, control (5 0 -AAUGGAAGACCACUCC CACUC-3 0 and 5 0 -GAGUGGGAGUGGUCUCCAUU-3 0 ) or HO-1 (5 0 -AAGGGAUUGAGCGCAACAAG-3 0 and 5 0 -CUU GUUGCGCUCAAUCUCCUU-3 0 ) siRNA were transfected, followed by H 2 O 2 treatment 24 h later.
The chemicals used were as follows: H 2 O 2 , cadmium chloride hemi(penta)hydrate (CdCl 2 ), hemin, cisplatin (CDDP), etoposide, Sin-1, NAC, rGSH and bilirubin.
Cell death and flow cytometry analysis Cell death was analysed by staining with fluorescein isothiocyanate-conjugated Annexin-V (Biomed Diagnostics, Singapore), and 20 mg/ml propidium iodide (Sigma, St Louis, MO, USA), prior to flow cytometric analysis as described by Sabapathy et al. (2004) . For determination of intracellular rGSH, cells were treated accordingly with H 2 O 2 as indicated and labelled with the Thioltracker dye (Invitrogen) for the last 30 min prior to harvest and flow cytometric analysis, as per manufacturer's instruction. Two-way analysis of variance was used to compare between two related experimental groups. P-value o0.05 was considered statistically significant.
Sodium dodecyl sulphate-PAGE and western blot analysis Cellular lysates were subjected to sodium dodecyl sulphate-PAGE on 10-12% gels and transferred onto a polyvinylidene difluoride membrane (Millipore, Billerica, MA, USA), as described by Vikhanskaya et al. (2007) , followed by hybridization with the following antibodies: anti-p53 (1C12), anti-phosphorp53 (Ser15), anti-acetyl p53 (Lys382) (all from Cell Signaling Technology, Danvers, MA, USA), anti-HO-1 (Hsp32) (Assay Designs, Belgium), anti-actin (Sigma) and anti-p53 human (DO-1) (Santa Cruz Biotechnology, Santa Cruz, CA, USA).
RNA analysis
A 3-mg weight of total RNA extracted using the Trizol reagent (Invitrogen) was used to synthesize single-stranded cDNA using Superscript II (Invitrogen). Taq polymerase (Qiagen, Germany) was used for all semi-quantitative RT-PCRs. Quantitative real-time PCR was performed using the SYBR mix (Fermentas, Germany). The primers and PCR conditions are indicated in Supplementary Table 1 .
Chromatin immunoprecipitation analysis
Protein complex was crossed-linked to DNA by adding formaldehyde directly to culture medium to a final concentration of 1% and incubated for 10 min at room temperature with shaking. Cells were lysed and immunoprecipitated using an anti-p53 (DO-1) antibody or a rabbit IgG control antibody, and the DNA was eluted for PCR analysis, essentially as described by Vikhanskaya et al. (2007) .
